All News

One urologist directs patients to the Johns Hopkins site, while another recommends the AUA homepage.

For men with high-risk pathology at radical prostatectomy, exposure to results of a genomic test that classifies 5-year risk of metastasis reduces decisional conflict, according to findings of a prospective study presented at the American Society of Clinical Oncology annual meeting in Chicago.

In this interview, Mark A. Moyad, MD, MPH, discusses non-drug interventions for urologic conditions, the difference between prescription drugs and nutraceuticals, and why a heart-healthy diet is a prostate-healthy diet.

In an effort to increase access to health care providers for members of the military and veterans, federal agencies are seeking ways to expand telemedicine and practice authority for advanced practice registered nurses (APRNs).

"Avoiding unnecessary biopsies should be a high-priority goal for us all," writes J. Brantley Thrasher, MD.

An ongoing phase II trial investigating abiraterone acetate (ZYTIGA) and enzalutamide (XTANDI) as treatment for men with chemotherapy-naïve metastatic castrate-resistant prostate cancer is aiming to characterize the effects of these targeted hormonal therapies on cognition and mood.

Multiparametric magnetic resonance imaging (mpMRI) identifies a significant percentage of men who present with an elevated serum PSA level who may safely avoid prostate biopsy, British researchers report.

Here are the answers to frequently asked questions about the technical, financial, and ethical issues surrounding penile transplantation surgery.

Applicants to urology residency programs have clear ideas about what they are seeking in a training program and a good understanding of the factors influencing their rankings, according to the findings of a survey presented at the AUA annual meeting San Diego.

In this installment in a series on MACRA, I will review the definition of APMs, how participating providers would be reimbursed under MACRA (as proposed), and the relevance to specialists, including urologists.

Once-daily treatment with cabozantinib (CABOMETYX), an oral tyrosine kinase inhibitor, significantly improves overall survival as well as progression-free survival and objective responses rates compared with everolimus (Afinitor) in previously treated patients with advanced renal cell carcinoma, according to final results from the phase III METEOR trial.

By now, most of you are relatively fluent in the urology diagnosis codes that affect payment for the services provided in the urology office. Of course, we are now facing the end of the ICD-10 “grace period,” and fears of denials for bad diagnosis codes are once again starting to circulate. This begs the question, what should you do now?

This review focuses on primary prevention of BPH and prostate cancer.

Among survivors of the most common types of cancer, bladder cancer survivors have the highest risk for developing a second primary cancer, according to a recent study.

You can withdraw money from an IRA at any time and for any reason, but it's important to keep in mind that most IRA withdrawals are at least partially taxable.

Sexual function/dysfunction topics discussed at the 2016 AUA included the findings of multiple studies on the effects of collagenase clostridium histolyticum (Xiaflex) treatment for Peyronie's disease, causes and treatments for ED, along with a study on patient satisfaction with implantable penile prostheses.

Other products discussed in this roundup include a smart-mobile connected ultrasound device, treatments for RCC, and more.

The emergence of robot-assisted laparoscopic donor nephrectomy (RLDN) and new findings regarding renal transplant patients' cancer risk highlight the discussions of transplantation/vascular surgery discussions at this year's AUA meeting.

Management of strictures after BPH surgery and a new clinical guideline for the treatment and diagnosis of male urethral stricture were among the major focuses at the 2016 AUA meeting.

Multiple studies on exosomes, data from the IMvigor 210 trial of atezolizumab (TECENTRIQ), and research on prehabilitation for cystectomy were among the highlights in bladder cancer from the 2016 AUA annual meeting.

Other female urology topics discussed at this year's AUA meeting include preoperative urodynamics for women undergoing prolapse surgery and a study on nocturia.

The 2016 Medicare trustees’ recent report that the Medicare trust fund will reach insolvency by 2028 is providing fodder for congressional Republicans who are pushing a plan to replace Obamacare, including numerous proposals that would dramatically change Medicare.

Robot-assisted laparoscopic prostatectomy effectiveness and cost, as welll as 3-D printed models, highlight the minimally invasive surgery discussions at this year's AUA meeting.

Other products discussed in this roundup include a plasma vaporization device, a laser fiber safety device, and more.

A men’s health expert explains implications of new data and how he will counsel patients.

Richard A. Watson, MD, explains why urologists need to be prepared to deal with men’s questions and recommend preventive steps related to Zika virus transmission.

“It appears that baseline PSA is a lot more predictive than either family history or race alone and should be used to risk stratify screening,” the co-lead author of a recent study tells Urology Times.

A recent study comparing 8 weeks of conventional radiation therapy with hypofractionated RT over 4 weeks appears to have practice-changing implications for men with intermediate-risk prostate cancer.

Techniques from experienced clinicians help transition placement of the prostatic urethral lift from the OR to an office setting.